Effects of a Paediatric Antimicrobial Stewardship Program on Antimicrobial Use and Quality of Prescriptions in Patients with Appendix-Related Intraabdominal Infections


Por: Simó-Nebot S, Velasco E, Rios-Barnés M, López-Ramos MG, Manuel Monsonis Cabedo, Urrea M, Jordán-García I, Ricard Casadevall Llandrich, Ormazábal-Kirchner D, Cuadras-Palleja D, Tarrado X, Prat J, Sánchez E, Noguera-Julian A and Fortuny-Guasch C

Publicada: 1 ene 2021 Ahead of Print: 23 dic 2020
Resumen:
The effectiveness of antimicrobial stewardship programs (ASP) in reducing antimicrobial use (AU) in children has been proved. Many interventions have been described suitable for different institution sizes, priorities, and patients, with surgical wards being one of the areas that may benefit the most. We aimed to describe the results on AU and length of stay (LOS) in a pre-post study during the three years before (2014-2016) and the three years after (2017-2019) implementation of an ASP based on postprescription review with feedback in children and adolescents admitted for appendix-related intraabdominal infections (AR-IAI) in a European Referral Paediatric University Hospital. In the postintervention period, the quality of prescriptions (QP) was also evaluated. Overall, 2021 AR-IAIs admissions were included. Global AU, measured both as days of therapy/100 patient days (DOT/100PD) and length of therapy (LOT), and global LOS remained unchanged in the postintervention period. Phlegmonous appendicitis LOS (p = 0.003) and LOT (p < 0.001) significantly decreased, but not those of other AR-IAI diagnoses. The use of piperacillin-tazobactam decreased by 96% (p = 0.044), with no rebound in the use of other Gram-negative broad-spectrum antimicrobials. A quasisignificant (p = 0.052) increase in QP was observed upon ASP implementation. Readmission and case fatality rates remained stable. ASP interventions were safe, and they reduced LOS and LOT of phlegmonous appendicitis and the use of selected broad-spectrum antimicrobials, while increasing QP in children with AR-IAI.

Filiaciones:
Simó-Nebot S:
 Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain

 Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain

Velasco E:
 Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain

Rios-Barnés M:
 Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain

López-Ramos MG:
 Pharmacy Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Manuel Monsonis Cabedo:
 Clinical Microbiology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Urrea M:
 Patient Safety Area-Infection Control Unit, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Jordán-García I:
 Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain

 Pediatric Intensive Care Unit, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

 Department of Paediatrics, University of Barcelona, 08007 Barcelona, Spain

Ricard Casadevall Llandrich:
 Management Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Ormazábal-Kirchner D:
 Computing Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Cuadras-Palleja D:
 Statistics Department, Sant Joan de Déu Research Foundation, 08950 Barcelona, Spain

Tarrado X:
 Paediatric Surgery Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Prat J:
 Paediatric Surgery Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain

Sánchez E:
 Blanquerna School of Health Science, Ramon Llull University, 08022 Barcelona, Spain

Noguera-Julian A:
 Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain

 Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain

 Statistics Department, Sant Joan de Déu Research Foundation, 08950 Barcelona, Spain

 Translational Research Network in Paediatric Infectious Diseases (RITIP), 28009 Madrid, Spain

Fortuny-Guasch C:
 Infectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Department of Paediatrics, Sant Joan de Déu Hospital Research Foundation, 08950 Barcelona, Spain

 Centre for Biomedical Network Research on Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain

 Statistics Department, Sant Joan de Déu Research Foundation, 08950 Barcelona, Spain

 Translational Research Network in Paediatric Infectious Diseases (RITIP), 28009 Madrid, Spain
ISSN: 20796382





Antibiotics-Basel
Editorial
MDPI, MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 10 Número: 1
Páginas:
WOS Id: 000609742000001
ID de PubMed: 33374676
imagen Green Submitted, gold

MÉTRICAS